Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract 2024 Banihashemi et al

[SNT Gatchaman]

Results
...
A total of 137 nurses were identified from the nursing office for initial eligibility screening. We excluded 73 participants because they did not meet the inclusion criteria (51 were not diagnosed with CFS; 22 declined to participate). The remaining 64 participants were then randomly assigned to either the intervention or placebo group.

At the end of the intervention, 4 participants (13.8%) in the Astragalus root extract group (n=29) and 24 (80%) in the control group (n=30) had CFS and at the 1-month follow-up, 5 participants (17.2%) in the Astragalus root extract group and 21 (70 %) in the control group (n=53) had CFS (no missing cases).

 

[forestglip]

At the end of the intervention, 4 participants (13.8%) in the Astragalus root extract group (n=29) and 24 (80%) in the control group (n=30) had CFS and at the 1-month follow-up, 5 participants (17.2%) in the Astragalus root extract group and 21 (70 %) in the control group (n=53) had CFS (no missing cases).

View attachment 21980 View attachment 21979

I mean, it seems pretty significant. Even if it's not actually CFS, which it probably isn't, it looks like this plant might be useful for something. Although, I barely understand any of the statistics on the second chart.

 

[Hutan]

A post on a new astragalus study moved here:
Evaluating myelophil, a 30% ethanol extract of Astragalus membranaceous and Salvia miltiorrhiza for alleviating fatigue in long COVID 2024 Young et al

 

[Mij]

The integrative/functional MD I was seeing 22 years ago recommended adaptogens when it very popular for ME/CFS. I tried a combo adaptogen formula with Astragaus and found it made me feel awful. My brain felt the same as when I took Elavil(amitriptyline).